These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 22740203

  • 1. Glutathione S-transferase Pi expression in invasive breast cancer and its relation with the clinical outcome.
    Franco RL, Schenka NG, Schenka AA, Rezende LF, Gurgel MS.
    J BUON; 2012; 17(2):259-64. PubMed ID: 22740203
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J, Tan PH, Thiyagarajan J, Bay BH.
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [Abstract] [Full Text] [Related]

  • 3. Discordance with local guidelines for adjuvant chemotherapy in breast cancer: reasons and effect on survival.
    Chéreau E, Coutant C, Gligorov J, Lesieur B, Antoine M, Daraï E, Uzan S, Rouzier R.
    Clin Breast Cancer; 2011 Mar; 11(1):46-51. PubMed ID: 21421522
    [Abstract] [Full Text] [Related]

  • 4. GST-pi expression correlates with oxidative stress and apoptosis in breast cancer.
    Huang J, Tan PH, Tan BK, Bay BH.
    Oncol Rep; 2004 Oct; 12(4):921-5. PubMed ID: 15375523
    [Abstract] [Full Text] [Related]

  • 5. Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen.
    Meattini I, Livi L, Saieva C, Franceschini D, Scotti V, Mangoni M, Loi M, Di Brina L, Zei G, Bonomo P, Greto D, Gelain E, Nori J, Sanchez LJ, Orzalesi L, Bianchi S, Biti G.
    Clin Breast Cancer; 2013 Aug; 13(4):247-53. PubMed ID: 23684167
    [Abstract] [Full Text] [Related]

  • 6. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer.
    Kawano A, Shimizu C, Hashimoto K, Kinoshita T, Tsuda H, Fujii H, Fujiwara Y.
    Breast Cancer; 2013 Apr 01; 20(2):145-51. PubMed ID: 22139727
    [Abstract] [Full Text] [Related]

  • 8. Influence of histology on the effectiveness of adjuvant chemotherapy in patients with hormone receptor positive invasive breast cancer.
    Truin W, Voogd AC, Vreugdenhil G, van der Sangen MJ, van Beek MW, Roumen RM.
    Breast; 2011 Dec 01; 20(6):505-9. PubMed ID: 21665471
    [Abstract] [Full Text] [Related]

  • 9. Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy.
    Parton M, Krajewski S, Smith I, Krajewska M, Archer C, Naito M, Ahern R, Reed J, Dowsett M.
    Clin Cancer Res; 2002 Jul 01; 8(7):2100-8. PubMed ID: 12114409
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.
    Torrisi R, Bagnardi V, Rotmensz N, Scarano E, Iorfida M, Veronesi P, Luini A, Viale G, Santoro A, Colleoni M, Goldhirsch A.
    Breast Cancer Res Treat; 2011 Apr 01; 126(2):431-41. PubMed ID: 21221766
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancer.
    Alpert LC, Schecter RL, Berry DA, Melnychuk D, Peters WP, Caruso JA, Townsend AJ, Batist G.
    Clin Cancer Res; 1997 May 01; 3(5):661-7. PubMed ID: 9815734
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment.
    Sweeney C, Ambrosone CB, Joseph L, Stone A, Hutchins LF, Kadlubar FF, Coles BF.
    Int J Cancer; 2003 Mar 01; 103(6):810-4. PubMed ID: 12516103
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of GST-pi expression in diffuse large B-cell lymphomas.
    Ribrag V, Koscielny S, Carpiuc I, Cebotaru C, Vande Walle H, Talbot M, Fenaux P, Bosq J.
    Leukemia; 2003 May 01; 17(5):972-7. PubMed ID: 12750712
    [Abstract] [Full Text] [Related]

  • 18. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO.
    J Clin Oncol; 2007 Oct 20; 25(30):4772-8. PubMed ID: 17876012
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF, Patrick RJ, Rybicki LA, Hicks D, Weng DE, Crowe JP.
    Ann Surg Oncol; 2006 Jun 20; 13(6):783-7. PubMed ID: 16604475
    [Abstract] [Full Text] [Related]

  • 20. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.
    J Surg Oncol; 2002 May 20; 80(1):4-11. PubMed ID: 11967899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.